🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs
4,713

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Page 27 of 99

  1. Benralizumab

    AstraZeneca

    Healthy Subjects

    phase 1 mab completed

    1 trial

  2. Bepranemab

    Lacuna Pharma Pty Ltd

    Progressive Supranuclear Palsy

    phase 1 small molecule active

    1 trial

  3. Bexarotene (Targretin®)

    LIGAND PHARMACEUTICALS INC

    Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

    phase 1 small molecule completed

    1 trial

  4. Bicalutamide

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  5. BiiB115 placebo is a sterile liquid for injection. the formulation composition of the placebo is identical to that of BIIB115 drug product minus the active ingredient, BIIB115

    Biogen

    Spinal muscular atrophy

    phase 1 small molecule active

    1 trial

  6. Bilateral Cerebellar deep brain stimulation

    Shandong Suncadia Medicine Co.,

    Stroke

    phase 1 other active

    1 trial

  7. Bimatoprost Ophthalmic Solution, 0.01%

    Amneal Pharma Europe Ltd

    Open-angle Glaucoma

    phase 1 small molecule active

    1 trial

  8. Bimzelx 320 mg solution for injection in pre-filled pen, Bimzelx 160 mg solution for injection in pre-filled syringe, Bimzelx 160 mg solution for injection in pre-filled syringe, Bimzelx 160 mg solution for injection in pre-filled pen, Bimzelx 160 mg solution for injection in pre-filled pen, Bimzelx 160 mg solution for injection in pre-filled syringe, Bimzelx 320 mg solution for injection in pre-filled syringe, Bimzelx 160 mg solution for injection in pre-filled pen, Bimzelx 160 mg solution for injection in

    Lacuna Pharma Pty Ltd

    Hidradenitis suppurativa, Axial spondyloarthritis, Moderate to Severe Plaque Psoriasis, Psoriatic arthritis

    phase 1 small molecule active

    1 trial

  9. Binimetinib

    Takeda

    ALK Gene Rearrangement

    phase 1 small molecule terminated

    1 trial

  10. Bio-equivalence of Rosuvastatin 10 mg

    Disc Medicine

    Healthy volunteers

    phase 1 other active

    1 trial

  11. BioLexa- Cohort 1

    Hoth Therapeutics

    Atopic Dermatitis

    phase 1 small molecule completed

    1 trial

  12. BioTTT001 injection

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

    Locally Advanced Breast Cancer (LABC)

    phase 1 mab terminated

    1 trial

  13. Bioavailability study of stiripentol after single oral administration of two different formulations (capsule and oral suspension) in 24 healthy subjects

    Biocodex

    Dravet syndrome

    phase 1 other active

    1 trial

  14. Bioequivalence Study of Empagliflozin

    Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.

    Not applicable (submitted trial is a BE study in healthy participants)

    phase 1 other active

    1 trial

  15. Bioequivalence clinical trial of dapagliflozin 10 mg tablets, after a single oral dose administration to healthy volunteers under fasting conditions.

    Laboratorios Tillomed Spain S.L.U

    Diabetes

    phase 1 other active

    1 trial

  16. Bioequivalence clinical trial of two formulations of linagliptin/metformin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  17. Bioequivalence clinical trial of two formulations of bilastine.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  18. Bioequivalence clinical trial of two formulations of canagliflozin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  19. Bioequivalence clinical trial of two formulations of dapagliflozin.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  20. Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  21. Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  22. Bioequivalence clinical trial of two formulations of edoxaban.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  23. Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  24. Bioequivalence clinical trial of two formulations of linagliptin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  25. Bioequivalence clinical trial of two formulations of linagliptin

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  26. Bioequivalence clinical trial of two formulations of linagliptin/metformin.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  27. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  28. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  29. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  30. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  31. Bioequivalence clinical trial of two formulations of rosuvastatin.

    Laboratorios Tillomed Spain S.L.U

    Hypercholesterolemia

    phase 1 other active

    1 trial

  32. Bioequivalence clinical trial of two formulations of vortioxetine.

    Laboratorios Tillomed Spain S.L.U

    Healthy volunteers

    phase 1 other active

    1 trial

  33. Bioequivalence of Amoxicillin and Clavulanic Acid 250 mg/62.5 mg/5 mL Powder for Oral Suspension versus Augmentin® Forte 250 mg/62.5 mg/5 mL Powder for Oral Suspension in Healthy Participants Under Fed Conditions

    BIAL - Portela & Ca

    No medical condition.

    phase 1 other active

    1 trial

  34. Bioequivalence of Amoxicillin and Clavulanic Acid 500 mg/125 mg Film-Coated Tablets in Healthy Participants Under Fed Conditions.

    BIAL - Portela & Ca

    No medical condition.

    phase 1 other active

    1 trial

  35. Bioequivalence of Amoxicillin and Clavulanic Acid 875 mg/125 mg Film-Coated Tablets in Healthy Participants Under Fed Conditions.

    BIAL - Portela & Ca

    No medical condition.

    phase 1 other active

    1 trial

  36. Bioequivalence of Apixaban 5 mg Film-Coated Tablets in Healthy Subjects Under Fasting Conditions.

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  37. Bioequivalence of Calcifediol monohydrate 0.266 mg Soft Capsules in Healthy Participants Under Fasting Conditions.

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  38. Bioequivalence of Cladribine 10 mg from two different products

    Lacuna Pharma Pty Ltd

    No therapeutic indication in the current trial with healthy volunteers. The intended indication is for treatment of adult patients with highly active relapsing multiple sclerosis (MS).

    phase 1 other active

    1 trial

  39. Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Non-Pregnant Female Participants.

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  40. Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Non-Pregnant Female Participants.

    Laboratorios Tillomed Spain S.L.U

    No medical condition

    phase 1 other active

    1 trial

  41. Bioequivalence of Lenvatinib 10 mg Capsules in Healthy Participants Under Fasting Conditions

    Lacuna Pharma Pty Ltd

    No medical condition

    phase 1 other active

    1 trial

  42. Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fasting Conditions.

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  43. Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fasting Conditions.

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  44. Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fed Conditions

    Lacuna Pharma Pty Ltd

    No medical condition

    phase 1 other active

    1 trial

  45. Bioequivalence of Lisdexamfetamine dimesylate 10 mg Capsules in Healthy Participants Under Fasting Conditions.

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  46. Bioequivalence of Lisdexamfetamine dimesylate 10 mg/mL Oral Solution in Healthy Participants Under Fasting Conditions.

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  47. Bioequivalence of Lisdexamfetamine dimesylate 20 mg Capsules in Healthy Participants Under Fasting Conditions.

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

  48. Bioequivalence of Lisdexamfetamine dimesylate 70 mg Capsules in Healthy Participants Under Fasting Conditions.

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.